Cargos activos de Edmund Benami
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Neuralight, Inc.
 Neuralight, Inc. Packaged SoftwareTechnology Services Neuralight, Inc. was founded in 2021 by Edmund Benami and Micha Y. Breakstone, with Micha Y. Breakstone serving as the CEO since then. The Israeli company is focused on transforming clinical development, diagnostics, and precision medicine in neurology with AI. The company is developing an AI-driven platform to accelerate and improve drug development and patient monitoring, as well as introduce precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone. | Director Técnico/Científico/I+D | 01/02/2021 | - |
| Fundador | 01/02/2021 | - |
Historial de carrera de Edmund Benami
Antiguos cargos conocidos de Edmund Benami.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Bugatone Ltd.
 Bugatone Ltd. Packaged SoftwareTechnology Services Bugatone Ltd. engages in the development of a software to improve audio quality and measure biographical data while listening to music or talking on the phone. The company was founded by Noam Petrank and Edmund Ben Ami on February 14, 2013 and is headquartered in Tel Aviv, Israel. | Fundador | 14/02/2013 | 01/06/2016 |
Estadísticas
Internacional
| Israel | 2 |
| Estados Unidos | 2 |
Operativa
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Technology Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Bugatone Ltd.
Bugatone Ltd. Packaged SoftwareTechnology Services Bugatone Ltd. engages in the development of a software to improve audio quality and measure biographical data while listening to music or talking on the phone. The company was founded by Noam Petrank and Edmund Ben Ami on February 14, 2013 and is headquartered in Tel Aviv, Israel. | Technology Services |
Neuralight, Inc.
Neuralight, Inc. Packaged SoftwareTechnology Services Neuralight, Inc. was founded in 2021 by Edmund Benami and Micha Y. Breakstone, with Micha Y. Breakstone serving as the CEO since then. The Israeli company is focused on transforming clinical development, diagnostics, and precision medicine in neurology with AI. The company is developing an AI-driven platform to accelerate and improve drug development and patient monitoring, as well as introduce precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone. | Technology Services |
- Bolsa de valores
- Insiders
- Edmund Benami
- Experiencia
